STOCKHOLM--(BUSINESS WIRE)--Vera Kallmeyer, member of Elekta’s Board of Directors, has passed away after a longer time of disease.
- Vera Kallmeyer was a highly appreciated board member with a comprehensive medical knowledge and business experience. Our thoughts are with Vera’s family, said Elekta’s President and CEO Tomas Puusepp.
Vera Kallmeyer M.D. , Ph.D. was the founding partner of the investment and consulting firm Equity4Health LLC and a consulting professor at the Department of Neurosurgery at Stanford University School of Medicine.
- Vera Kallmeyer has been a member of Elekta’s Board since 2008. She shared the Board’s strong commitment for Elekta and during these years she has given valuable contributions to a successful work in the Board, said Elekta’s Chairman of the Board Akbar Seddigh.
***
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
This information was brought to you by Cision http://www.cisionwire.com